We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+5.93%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$28.6B
AUM Growth
+$1.5B
Cap. Flow
+$262M
Cap. Flow %
0.92%
Top 10 Hldgs %
43.01%
Holding
291
New
10
Increased
102
Reduced
100
Closed
10

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$67.8M
2
MSFT icon
Microsoft
MSFT
+$65M
3
AAPL icon
Apple
AAPL
+$45M
4
AMZN icon
Amazon
AMZN
+$42.8M
5
PM icon
Philip Morris
PM
+$40.2M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$56.2M
2
META icon
Meta Platforms (Facebook)
META
+$38.9M
3
AXP icon
American Express
AXP
+$32.9M
4
MS icon
Morgan Stanley
MS
+$32.6M
5
PG icon
Procter & Gamble
PG
+$31.9M

Sector Composition

Rank Sector Weight
1 Technology 23.05%
2 Consumer Staples 18.27%
3 Financials 17.61%
4 Energy 12.56%
5 Healthcare 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.96T
$2.63B 9.21%
15,955,747
+305,254
+2% +$45M
MSFT icon
2
Microsoft
MSFT
$2.89T
$2.1B 7.36%
7,295,390
+254,666
+4% +$65M
PM icon
3
Philip Morris
PM
$310B
$1.28B 4.48%
13,160,745
+402,983
+3% +$40.2M
KO icon
4
Coca-Cola
KO
$384B
$1.21B 4.23%
19,486,534
-462,352
-2% -$28M
XOM icon
5
ExxonMobil
XOM
$651B
$1.16B 4.05%
10,549,530
+173,818
+2% +$19.2M
CVX icon
6
Chevron
CVX
$383B
$947M 3.31%
5,803,717
-164,093
-3% -$27.5M
TROW icon
7
T. Rowe Price
TROW
$25.5B
$854M 2.99%
7,563,540
-274,395
-4% -$31.4M
NVO
8
Novo Nordisk
NVO
$228B
$840M 2.94%
10,560,714
+327,976
+3% +$23.3M
PG icon
9
Procter & Gamble
PG
$341B
$641M 2.24%
4,309,273
-223,107
-5% -$31.9M
TXN icon
10
Texas Instruments
TXN
$248B
$626M 2.19%
3,366,979
+38,274
+1% +$6.73M
JPM icon
11
JPMorgan Chase
JPM
$919B
$610M 2.14%
4,684,848
-147,552
-3% -$20.2M
MCD icon
12
McDonald's
MCD
$193B
$606M 2.12%
2,166,417
+29,340
+1% +$7.86M
V icon
13
Visa
V
$703B
$601M 2.1%
2,665,847
+44,471
+2% +$9.9M
GOOG icon
14
Alphabet (Google) Class C
GOOG
$4.1T
$582M 2.04%
5,594,653
-9,905
-0.2% -$956K
HES
15
DELISTED
Hess
HES
$577M 2.02%
4,359,523
+231,403
+6% +$32.2M
PEP icon
16
PepsiCo
PEP
$196B
$542M 1.9%
2,972,454
+54,443
+2% +$9.52M
AMZN icon
17
Amazon
AMZN
$2.43T
$537M 1.88%
5,195,716
+443,290
+9% +$42.8M
MO icon
18
Altria Group
MO
$125B
$514M 1.8%
11,519,906
+6,749
+0.1% +$310K
UNH icon
19
UnitedHealth
UNH
$383B
$508M 1.78%
1,074,391
+62,981
+6% +$30.4M
UNP icon
20
Union Pacific
UNP
$174B
$488M 1.71%
2,423,006
+90,395
+4% +$18.3M
SPGI icon
21
S&P Global
SPGI
$124B
$473M 1.65%
1,370,661
+2,971
+0.2% +$1.05M
EPD icon
22
Enterprise Products Partners
EPD
$83.7B
$429M 1.5%
16,569,305
+603,827
+4% +$15.5M
APD icon
23
Air Products & Chemicals
APD
$65.7B
$421M 1.47%
1,464,515
+17,688
+1% +$5.16M
ABT icon
24
Abbott
ABT
$188B
$413M 1.45%
4,079,297
-189,866
-4% -$20M
BLK icon
25
Blackrock
BLK
$168B
$381M 1.33%
568,686
-140
-0% -$98.6K
1
2 3 4 5

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fayez Sarofim & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Fayez Sarofim & Co held 291 positions worth $28.6B, up 5.6% from $27.1B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q1 2023 filing shows 10 new, 102 increased, 100 reduced and 10 closed positions. Its largest new stake was MSCI: 9,600 shares worth $5.37M. The largest sale was Johnson & Johnson, an estimated $56.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Staples and Financials.

  • Fayez Sarofim & Co's largest Q1 2023 buy was MSCI: 9,600 shares worth $5.37M.
  • Fayez Sarofim & Co added most to AstraZeneca in Q1 2023, an estimated $67.8M increase.
  • Fayez Sarofim & Co's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $56.2M.
  • Fayez Sarofim & Co fully exited Cohen & Steers in Q1 2023, selling an estimated $3.23M.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $28.6B portfolio in Q1 2023.
  • Fayez Sarofim & Co opened 10 new positions and closed 10 in Q1 2023.
  • Fayez Sarofim & Co's portfolio value rose 5.6% quarter-over-quarter to $28.6B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2023, filed 11 May 2023.